PK/ADA Therapeutic Drug ELISA Kit

Creative Diagnostics offers PK and ADA detection ELISA kits for quantifying drug and anti-drug antibody levels in serum/plasma, ensuring high accuracy, sensitivity, and specificity. Designed for therapeutic monoclonal antibodies, fusion proteins, ADCs, and peptide biologics, our solutions provide comprehensive support across preclinical research, clinical trials, and therapeutic drug monitoring (TDM), accelerating drug development and personalized medicine.

Introduction to pharmacokinetic and anti-drug antibodies test

Pharmacokinetic (PK) studies are essential in drug development, employing analytical methods to characterize the time course of drug absorption, distribution, metabolism, and excretion (ADME) in biological systems. These studies provide critical parameters that guide dosing regimen optimization and ensure therapeutic efficacy and safety. Due to their structural complexity, monoclonal antibodies, proteins, and peptide drugs require particularly rigorous PK analysis.

In the era of precision medicine, these biologics have become central to modern therapy because of their high specificity and potency. However, their potential immunogenicity may trigger anti-drug antibody (ADA) responses that compromise efficacy and cause adverse reactions. Therefore, reliable ADA detection is crucial for evaluating immunogenicity in both preclinical and clinical studies. While various platforms such as ELISA, ECL, SPR, and RIA are available, ELISA remains the most widely used method for robust and sensitive ADA assessment.

Products are categorized below for easy navigation. For further assistance, please contact our sales team.